OXCARBAZEPINE

Product NDC
60505-4128
11-digit product format
605054128
Labeler code
60505
Product ID
60505-4128_f106ef3d-7def-b2e5-2428-60ecd16326f0
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
OXCARBAZEPINE
Dosage form
TABLET, EXTENDED RELEASE
Route
ORAL
Labeler
Apotex Corp.
Application
ANDA213369
Marketing category
ANDA
Marketing start
2024-09-03
Substance
OXCARBAZEPINE
Active strength
150 mg/1
Pharmacologic classes
Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]
NDC exclude flag
No
Listing certified through
2026-12-31
Current FDA listing
Yes

Source provenance: Browse the complete Orange Book source catalog · source snapshot 1.

Orange Book products#

Current product rows page 1 of 1 · 3 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
A213369-001OXCARBAZEPINEOXCARBAZEPINE150MGTABLET, EXTENDED RELEASE / ORALAB2023-07-13
A213369-002OXCARBAZEPINEOXCARBAZEPINE300MGTABLET, EXTENDED RELEASE / ORALAB2023-07-13
A213369-003OXCARBAZEPINEOXCARBAZEPINE600MGTABLET, EXTENDED RELEASE / ORALAB2023-07-13

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 3 matching rows.

Application-product, TE code table
Application-productTE code
A213369-001AB
A213369-002AB
A213369-003AB

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 2 · 60 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-02-19 14:30 UTC2026-02A213369-001OXCARBAZEPINE150MGTABLET, EXTENDED RELEASE / ORALAB2023-07-13011fe1cb6892…
2026-02-19 14:30 UTC2026-02A213369-002OXCARBAZEPINE300MGTABLET, EXTENDED RELEASE / ORALAB2023-07-13011fe1cb6892…
2026-02-19 14:30 UTC2026-02A213369-003OXCARBAZEPINE600MGTABLET, EXTENDED RELEASE / ORALAB2023-07-13011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A213369-001OXCARBAZEPINE150MGTABLET, EXTENDED RELEASE / ORALAB2023-07-1331067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A213369-002OXCARBAZEPINE300MGTABLET, EXTENDED RELEASE / ORALAB2023-07-1331067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A213369-003OXCARBAZEPINE600MGTABLET, EXTENDED RELEASE / ORALAB2023-07-1331067a03dcf5…
2025-08-23 18:47 UTC2025-08A213369-001OXCARBAZEPINE150MGTABLET, EXTENDED RELEASE / ORALAB2023-07-136a471c1ec25d…
2025-08-23 18:47 UTC2025-08A213369-002OXCARBAZEPINE300MGTABLET, EXTENDED RELEASE / ORALAB2023-07-136a471c1ec25d…
2025-08-23 18:47 UTC2025-08A213369-003OXCARBAZEPINE600MGTABLET, EXTENDED RELEASE / ORALAB2023-07-136a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A213369-001OXCARBAZEPINE150MGTABLET, EXTENDED RELEASE / ORALAB2023-07-13fd3edfee7708…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A213369-002OXCARBAZEPINE300MGTABLET, EXTENDED RELEASE / ORALAB2023-07-13fd3edfee7708…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A213369-003OXCARBAZEPINE600MGTABLET, EXTENDED RELEASE / ORALAB2023-07-13fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02A213369-001OXCARBAZEPINE150MGTABLET, EXTENDED RELEASE / ORALAB2023-07-13b8a1b40f171c…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02A213369-002OXCARBAZEPINE300MGTABLET, EXTENDED RELEASE / ORALAB2023-07-13b8a1b40f171c…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02A213369-003OXCARBAZEPINE600MGTABLET, EXTENDED RELEASE / ORALAB2023-07-13b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01A213369-001OXCARBAZEPINE150MGTABLET, EXTENDED RELEASE / ORALAB2023-07-1303ed91905a0d…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01A213369-002OXCARBAZEPINE300MGTABLET, EXTENDED RELEASE / ORALAB2023-07-1303ed91905a0d…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01A213369-003OXCARBAZEPINE600MGTABLET, EXTENDED RELEASE / ORALAB2023-07-1303ed91905a0d…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12A213369-001OXCARBAZEPINE150MGTABLET, EXTENDED RELEASE / ORALAB2023-07-132680178bc6a6…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12A213369-002OXCARBAZEPINE300MGTABLET, EXTENDED RELEASE / ORALAB2023-07-132680178bc6a6…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12A213369-003OXCARBAZEPINE600MGTABLET, EXTENDED RELEASE / ORALAB2023-07-132680178bc6a6…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09A213369-001OXCARBAZEPINE150MGTABLET, EXTENDED RELEASE / ORALAB2023-07-135bbf6a4d5a75…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09A213369-002OXCARBAZEPINE300MGTABLET, EXTENDED RELEASE / ORALAB2023-07-135bbf6a4d5a75…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09A213369-003OXCARBAZEPINE600MGTABLET, EXTENDED RELEASE / ORALAB2023-07-135bbf6a4d5a75…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11A213369-001OXCARBAZEPINE150MGTABLET, EXTENDED RELEASE / ORALAB2023-07-13d8e5a09893c0…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11A213369-002OXCARBAZEPINE300MGTABLET, EXTENDED RELEASE / ORALAB2023-07-13d8e5a09893c0…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11A213369-003OXCARBAZEPINE600MGTABLET, EXTENDED RELEASE / ORALAB2023-07-13d8e5a09893c0…
2024-10-29 15:01 UTC2024-10A213369-001OXCARBAZEPINE150MGTABLET, EXTENDED RELEASE / ORALAB2023-07-13d06236e962d9…
2024-10-29 15:01 UTC2024-10A213369-002OXCARBAZEPINE300MGTABLET, EXTENDED RELEASE / ORALAB2023-07-13d06236e962d9…
2024-10-29 15:01 UTC2024-10A213369-003OXCARBAZEPINE600MGTABLET, EXTENDED RELEASE / ORALAB2023-07-13d06236e962d9…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08A213369-001OXCARBAZEPINE150MGTABLET, EXTENDED RELEASE / ORAL2023-07-1379d66fd596c7…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08A213369-002OXCARBAZEPINE300MGTABLET, EXTENDED RELEASE / ORAL2023-07-1379d66fd596c7…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08A213369-003OXCARBAZEPINE600MGTABLET, EXTENDED RELEASE / ORAL2023-07-1379d66fd596c7…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07A213369-001OXCARBAZEPINE150MGTABLET, EXTENDED RELEASE / ORAL2023-07-13301d65b070ca…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07A213369-002OXCARBAZEPINE300MGTABLET, EXTENDED RELEASE / ORAL2023-07-13301d65b070ca…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07A213369-003OXCARBAZEPINE600MGTABLET, EXTENDED RELEASE / ORAL2023-07-13301d65b070ca…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06A213369-001OXCARBAZEPINE150MGTABLET, EXTENDED RELEASE / ORAL2023-07-131e350fbaab3a…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06A213369-002OXCARBAZEPINE300MGTABLET, EXTENDED RELEASE / ORAL2023-07-131e350fbaab3a…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06A213369-003OXCARBAZEPINE600MGTABLET, EXTENDED RELEASE / ORAL2023-07-131e350fbaab3a…
2024-05-31 18:47 UTC2024-05A213369-001OXCARBAZEPINE150MGTABLET, EXTENDED RELEASE / ORAL2023-07-138072bd15b7f6…

Observed Orange Book normalized TE history#

Captured, Edition, Application-product table
CapturedEditionApplication-productTE codeOrderSource SHA-256
2026-02-19 14:30 UTC2026-02A213369-001AB1011fe1cb6892…
2026-02-19 14:30 UTC2026-02A213369-002AB1011fe1cb6892…
2026-02-19 14:30 UTC2026-02A213369-003AB1011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A213369-001AB131067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A213369-002AB131067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A213369-003AB131067a03dcf5…
2025-08-23 18:47 UTC2025-08A213369-001AB16a471c1ec25d…
2025-08-23 18:47 UTC2025-08A213369-002AB16a471c1ec25d…
2025-08-23 18:47 UTC2025-08A213369-003AB16a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A213369-001AB1fd3edfee7708…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A213369-002AB1fd3edfee7708…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A213369-003AB1fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02A213369-001AB1b8a1b40f171c…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02A213369-002AB1b8a1b40f171c…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02A213369-003AB1b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01A213369-001AB103ed91905a0d…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01A213369-002AB103ed91905a0d…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01A213369-003AB103ed91905a0d…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12A213369-001AB12680178bc6a6…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12A213369-002AB12680178bc6a6…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12A213369-003AB12680178bc6a6…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09A213369-001AB15bbf6a4d5a75…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09A213369-002AB15bbf6a4d5a75…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09A213369-003AB15bbf6a4d5a75…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11A213369-001AB1d8e5a09893c0…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11A213369-002AB1d8e5a09893c0…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11A213369-003AB1d8e5a09893c0…
2024-10-29 15:01 UTC2024-10A213369-001AB1d06236e962d9…
2024-10-29 15:01 UTC2024-10A213369-002AB1d06236e962d9…
2024-10-29 15:01 UTC2024-10A213369-003AB1d06236e962d9…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06A213369-001AB1a50c72e98297…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06A213369-002AB1a50c72e98297…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06A213369-003AB1a50c72e98297…

Additional Listing Data#

Finished product
Yes
Brand name base
OXCARBAZEPINE
Listing expiration
2026-12-31

Active Ingredients#

Ingredient, Strength table
IngredientStrength
OXCARBAZEPINE150 mg/1

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
VZI5B1W380Internal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 3 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
1365653Internal RxNorm lookup
1365842Internal RxNorm lookup
1365844Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
a20e4a95-8ee1-e702-003e-e353ec1ee133Available on FDA.report

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
ca2a6da1-5711-44d0-9e79-c84d4265f98bProduct name320250724
536d5b6b-66f1-478b-2670-88fd15947e3bProduct name720250218

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
60505-4128-5OXCARBAZEPINE500 in 1 BOTTLETABLET, EXTENDED RELEASE5006
60505-4128-7OXCARBAZEPINE100 in 1 BOTTLETABLET, EXTENDED RELEASE1006

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
60505-4128-7EA - Each60505-4128089b4718-99de-4c5c-8718-f383d29c2b3412024-09-09

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
60505-4128OXCARBAZEPINE TABLET, EXTENDED RELEASE [APOTEX CORP.]5Current NDC, 2 package rows20240913_a20e4a95-8ee1-e702-003e-e353ec1ee133.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
OXCARBAZEPINEOXCARBAZEPINEApotex Corp.a20e4a95-8ee1-e702-003e-e353ec1ee1332025-09-19Warnings, Adverse reactionsExact identifier
application applno (ANDA): 213369
application number: ANDA213369
ndc (product): 60505-4128

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYDailyMedSPL version
1365653OXcarbazepine 150 MG 24HR Extended Release Oral TabletPSNa20e4a95-8ee1-e702-003e-e353ec1ee1336
1365842OXcarbazepine 300 MG 24HR Extended Release Oral TabletPSNa20e4a95-8ee1-e702-003e-e353ec1ee1336
1365844OXcarbazepine 600 MG 24HR Extended Release Oral TabletPSNa20e4a95-8ee1-e702-003e-e353ec1ee1336
136565324 HR oxcarbazepine 150 MG Extended Release Oral TabletSCDa20e4a95-8ee1-e702-003e-e353ec1ee1336
136584224 HR oxcarbazepine 300 MG Extended Release Oral TabletSCDa20e4a95-8ee1-e702-003e-e353ec1ee1336
136584424 HR oxcarbazepine 600 MG Extended Release Oral TabletSCDa20e4a95-8ee1-e702-003e-e353ec1ee1336
1365653oxcarbazepine 150 MG 24 HR Extended Release Oral TabletSYa20e4a95-8ee1-e702-003e-e353ec1ee1336
1365842oxcarbazepine 300 MG 24 HR Extended Release Oral TabletSYa20e4a95-8ee1-e702-003e-e353ec1ee1336
1365844oxcarbazepine 600 MG 24 HR Extended Release Oral TabletSYa20e4a95-8ee1-e702-003e-e353ec1ee1336

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionMarketing startSampleExclude flagStatus
60505-4128-560505412805500 TABLET, EXTENDED RELEASE in 1 BOTTLE (60505-4128-5) 2024-09-03NoNoCurrent
60505-4128-760505412807100 TABLET, EXTENDED RELEASE in 1 BOTTLE (60505-4128-7) 2024-09-03NoNoCurrent